WTA
RMD icon

Washington Trust Advisors’s ResMed RMD Stock Holding History

Washington Trust Advisors’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.6M Sell
115,745
-4,079
-3% -$845K 1.67% 15
2026
Q1 		$26.9M Sell
119,824
-2,741
-2% -$683K 2.17% 13
2025
Q4 		$29.5M Sell
122,565
-1,498
-1% -$383K 2.26% 14
2025
Q3 		$34M Sell
124,063
-3,910
-3% -$1.07M 2.58% 12
2025
Q2 		$33M Sell
127,973
-342
-0.3% -$81.6K 2.68% 11
2025
Q1 		$28.7M Sell
128,315
-368
-0.3% -$85.9K 2.55% 11
2024
Q4 		$29.4M Sell
128,683
-1,789
-1% -$431K 2.46% 12
2024
Q3 		$31.9M Sell
130,472
-1,614
-1% -$361K 2.74% 10
2024
Q2 		$25.3M Sell
132,086
-2,824
-2% -$573K 2.32% 13
2024
Q1 		$26.7M Sell
134,910
-1,473
-1% -$270K 2.45% 14
2023
Q4 		$23.5M Sell
136,383
-271
-0.2% -$41.6K 2.25% 14
2023
Q3 		$20.2M Buy
136,654
+6,851
+5% +$1.24M 2.07% 16
2023
Q2 		$28.4M Sell
129,803
-290
-0.2% -$64.6K 2.75% 9
2023
Q1 		$28.5M Sell
130,093
-892
-0.7% -$194K 2.9% 7
2022
Q4 		$27.3M Sell
130,985
-2,925
-2% -$643K 2.98% 7
2022
Q3 		$29.2M Sell
133,910
-3,403
-2% -$775K 2.74% 7
2022
Q2 		$28.8M Buy
137,313
+1,961
+1% +$417K 2.54% 8
2022
Q1 		$32.8M Sell
135,352
-1,042
-0.8% -$252K 2.33% 11
2021
Q4 		$35.5M Buy
+136,394
New +$35.4M 2.4% 9

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Washington Trust Advisors's RMD Position: Q2 2026 in Review

Washington Trust Advisors reduced its ResMed (RMD) stake by 3.4% in Q2 2026, selling an estimated $845K and leaving 115,745 shares worth $22.6M. The position accounts for 1.67% of the portfolio, ranked #15.

Washington Trust Advisors first reported a position in RMD in Q4 2021 and has held it in 19 quarters since. The position peaked at $35.5M in Q4 2021. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Washington Trust Advisors held 115,745 shares of ResMed worth $22.6M as of Q2 2026.
  • Washington Trust Advisors sold 4,079 ResMed shares in Q2 2026, an estimated $845K.
  • ResMed made up 1.67% of Washington Trust Advisors's portfolio in Q2 2026, its #15 holding.
  • Washington Trust Advisors first reported a position in ResMed in Q4 2021 and has held it in 19 quarters since.
  • Washington Trust Advisors's ResMed position peaked at $35.5M in Q4 2021.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Washington Trust Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.